Targeted antiangiogenic therapy for cancer using vitaxin: A humanized monoclonal antibody to the integrin α(v)β3

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 3056-3061

  Gutheil, John C ^a,e   Campbell, Thomas N ^a   Pierce, Paul R ^b   Watkins, Jeffry D ^c   Huse, William D ^c   Bodkin, David J ^a   Cheresh, David A ^d  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

^b MEDIMMUNE   (United States)

^c Applied Molecular Evolution   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e VICAL INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN RECEPTOR; MONOCLONAL ANTIBODY LM 609;

ADULT; ADVANCED CANCER; AGED; ANGIOGENESIS; ARTICLE; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; HUMAN; MALE; METASTASIS; PATIENT SELECTION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; TUMOR BLOOD FLOW; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, VITRONECTIN;

EID: 0033870756     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. 5 in ocular neovascular diseases. Proc. Natl. Acad. Sci. USA, 93: 9764-9769, 1996.
2. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
3. 3 for angiogenesis. Science (Washington DC), 264: 569-571, 1994.
4. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79: 1157-1164, 1994.
5. Dameron, K. M., Volpert, O. V., Tainsky, M. A., and Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science (Washington DC), 265: 1582-1584, 1994.
6. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance (see comments). Nature (Lond.), 390: 404-407, 1997.
7. Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285: 1182-1186, 1971.
8. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
9. 3 blocks human breast cancer growth and angiogenesis in human skin (see comments). J. Clin. Invest., 96: 1815-1822, 1995.
10. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.
11. 3-targeted magnetic resonance imaging. Nat. Med., 4: 623-626, 1998.
12. Auerbach, W., and Auerbach, R. Angiogenesis inhibition: a review. Pharmacol. Ther., 63: 265-311, 1994.
13. 3 antagonist (see comments). J. Clin. Invest., 103: 47-54, 1999.
14. Trang, J. M., LoBuglio, A. F., Wheeler, R. H., Harvey, E. B., Sun, L., Ghrayeb, J., and Khazaeli, M. B. Pharmacokinetics of a mouse/ human chimeric monoclonal antibody (C-17-1A) in metastatic adenocarcinoma patients. Pharm. Res. (NY), 7: 587-592, 1990.
15. 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J. Cell Biol., 121: 163-170, 1993.
16. LoBuglio, A. F., Wheeler, R. H., Trang, J., Haynes, A., Rogers, K., Harvey, E. B., Sun, L., Ghrayeb, J., and Khazaeli, M. B. Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc. Natl. Acad. Sci. USA, 86: 4220-4224, 1989.
17. Relf, M., LeJeune, S., Scott, P. A., Fox, S., Smith, K., Leek, R., Moghaddam, A., Whitehouse, R., Bicknell, R., and Harris, A. L. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res., 57: 963-969, 1997.